¿Ciencia abierta para intereses privados? la lógica de la ciencia abierta y la comercialización de la investigación

Los conflictos de intereses, los casos de fraude científico y las limitaciones a la investigación por las leyes de propiedad intelectual han llevado a cuestionar la idoneidad epistémica y de justicia social de la investigación financiada por la industria. El ideal de Ciencia Abierta –que promueve la...

Full description

Autores:: Fernández Pinto, Manuela

Tipo de recurso:: Article of journal

Fecha de publicación:: 2022

Institución:: Universidad Externado de Colombia

Repositorio:: Biblioteca Digital Universidad Externado de Colombia

Idioma:: spa

id	uexternad2_e0824af8a4abbd8136378300b093a61d
oai_identifier_str	oai:bdigital.uexternado.edu.co:001/12302
network_acronym_str	uexternad2
network_name_str	Biblioteca Digital Universidad Externado de Colombia
repository_id_str
dc.title.spa.fl_str_mv	¿Ciencia abierta para intereses privados? la lógica de la ciencia abierta y la comercialización de la investigación
dc.title.translated.eng.fl_str_mv	Open science for private interests? How the logic of open science contributes to the commercialization of research
title	¿Ciencia abierta para intereses privados? la lógica de la ciencia abierta y la comercialización de la investigación
spellingShingle	¿Ciencia abierta para intereses privados? la lógica de la ciencia abierta y la comercialización de la investigación commercialization of science, open science, open access, industry-funded research, democratization of science L23, I15, I23 comercialización de la ciencia, ciencia abierta, acceso abierto, investigación financiada por la industria, democratización de la ciencia L23, I15, I23 comercialização da ciência, ciência aberta, acesso aberto, pesquisa financiada pela indústria, democratização da ciência L23, I15, I23
title_short	¿Ciencia abierta para intereses privados? la lógica de la ciencia abierta y la comercialización de la investigación
title_full	¿Ciencia abierta para intereses privados? la lógica de la ciencia abierta y la comercialización de la investigación
title_fullStr	¿Ciencia abierta para intereses privados? la lógica de la ciencia abierta y la comercialización de la investigación
title_full_unstemmed	¿Ciencia abierta para intereses privados? la lógica de la ciencia abierta y la comercialización de la investigación
title_sort	¿Ciencia abierta para intereses privados? la lógica de la ciencia abierta y la comercialización de la investigación
dc.creator.fl_str_mv	Fernández Pinto, Manuela
dc.contributor.author.spa.fl_str_mv	Fernández Pinto, Manuela
dc.subject.eng.fl_str_mv	commercialization of science, open science, open access, industry-funded research, democratization of science L23, I15, I23
topic	commercialization of science, open science, open access, industry-funded research, democratization of science L23, I15, I23 comercialización de la ciencia, ciencia abierta, acceso abierto, investigación financiada por la industria, democratización de la ciencia L23, I15, I23 comercialização da ciência, ciência aberta, acesso aberto, pesquisa financiada pela indústria, democratização da ciência L23, I15, I23
dc.subject.spa.fl_str_mv	comercialización de la ciencia, ciencia abierta, acceso abierto, investigación financiada por la industria, democratización de la ciencia L23, I15, I23 comercialização da ciência, ciência aberta, acesso aberto, pesquisa financiada pela indústria, democratização da ciência L23, I15, I23
description	Los conflictos de intereses, los casos de fraude científico y las limitaciones a la investigación por las leyes de propiedad intelectual han llevado a cuestionar la idoneidad epistémica y de justicia social de la investigación financiada por la industria. El ideal de Ciencia Abierta –que promueve la transparencia, la colaboración y la rendición de cuentas– parece abordar las limitaciones de la investigación impulsada comercialmente. Sin embargo, el movimiento de Ciencia Abierta se centra en la investigación financiada con fondos públicos, alienta los lazos con el sector privado y crea nuevas estrategias para comercializar la ciencia. Así, la Ciencia Abierta termina contribuyendo a la comercialización de la ciencia y no a superar sus limitaciones; y la asimetría entre ciencia privada y pública, presente en la actual apelación a la ciencia abierta, termina comprometiendo los valores que promueve el ideal.
publishDate	2022
dc.date.accessioned.none.fl_str_mv	2022-07-01 14:04:06 2022-09-09T21:19:30Z
dc.date.available.none.fl_str_mv	2022-07-01 14:04:06 2022-09-09T21:19:30Z
dc.date.issued.none.fl_str_mv	2022-07-01
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_6501
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.content.spa.fl_str_mv	Text
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.local.eng.fl_str_mv	Journal article
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ARTREF
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.doi.none.fl_str_mv	10.18601/01245996.v24n47.08
dc.identifier.eissn.none.fl_str_mv	2346-2450
dc.identifier.issn.none.fl_str_mv	0124-5996
dc.identifier.uri.none.fl_str_mv	https://bdigital.uexternado.edu.co/handle/001/12302
dc.identifier.url.none.fl_str_mv	https://doi.org/10.18601/01245996.v24n47.08
identifier_str_mv	10.18601/01245996.v24n47.08 2346-2450 0124-5996
url	https://bdigital.uexternado.edu.co/handle/001/12302 https://doi.org/10.18601/01245996.v24n47.08
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.bitstream.none.fl_str_mv	https://revistas.uexternado.edu.co/index.php/ecoins/article/download/7964/11990
dc.relation.citationedition.spa.fl_str_mv	Núm. 47 , Año 2022 : Julio-Diciembre
dc.relation.citationendpage.none.fl_str_mv	201
dc.relation.citationissue.spa.fl_str_mv	47
dc.relation.citationstartpage.none.fl_str_mv	179
dc.relation.citationvolume.spa.fl_str_mv	24
dc.relation.ispartofjournal.spa.fl_str_mv	Revista de Economía Institucional
dc.relation.references.spa.fl_str_mv	Andrade, C. (2015). The primary outcome measure and its importance in clinical trials. Journal of Clinical Psychiatry, 76(10), e1320-e1323. Bartling, S. y Friesike, S. (2014). Towards another scientific revolution. En S. Bartling y S. Friesike (eds.), Opening science: The evolving guide on how the internet is changing research (pp. 3-16). Dordrecht, Netherlands: Springer. Bekelman, J., Li, Y. y Gross, C. (2003). Scope and impact of financial conflicts of interest in biomedical research: A systematic review. Journal of the American Medical Association, 289(4), 454-465. Biddle, J. (2007). Lessons from the Vioxx debacle: What the privatization of science can teach us about social epistemology. Social Epistemology, 21(1), 21-39. Biddle, J. (2014). Can patents prohibit research? On the social epistemology of patenting and licensing in science. Studies in History and Philosophy of Science, 45(1), 14-23. Bok, D. (2003). Universities in the marketplace: The commercialization of higher education. Princeton, NJ: Princeton University Press. Doucet, M. y Sismondo, S. (2008). Evaluating solutions to sponsorship bias. Journal of Medical Ethics, 34(8), 627-630. Douglas, H. (2009). Science, policy, and the value-free ideal. Pittsburgh, PA: University of Pittsburgh Press. Elliott, K. (2008). Scientific judgment and the limits of conflict-ofinterest policies. Accountability in Research Policies and Quality Assurance, 15(1), 1-29. Elliott, K. (2019). The kaleidoscope of citizen science. Narrative Inquiry in Bioethics, 9(1), 47-52. EU Presidency. (2016). Amsterdam call for action on open science, [https://f-origin.hypotheses.org/wp-content/blogs.dir/1244/files/ 2016/06/amsterdam-call-for-action-on-open-science.pdf ]. European Commission for Research and Innovation. (2016). Guidelines on open access to scientific publications and research data in horizon 2020, [http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/oa_pilot/h2020-hi-oa-pilot-guide_en.pdf ]. Eurostat. (2018). The EU in the World, [https://ec.europa.eu/ eurostat/en/web/products-statistical-books/-/KS-EX-18-001]. Fecher, B. y Friesike, S. (2014). Open science: One term, five schools of thought. En S. Bartling y S. Friesike (eds.), Opening science: The evolving guide on how the internet is changing research (pp. 17-47). Dordrecht, Netherlands: Springer. Fernández Pinto, M. (2017). To know or better not to: Agnotology and the social construction of ignorance in commercially driven research. Science & Technology Studies, 30(2), 53-72. Fernández Pinto, M. (2018). Democratizing strategies for industryfunded medical research: A cautionary tale. Philosophy of Science, 85(5), 882-894. G8 Summit. (2013). Science Ministers statement, [https://www.gov.uk/government/publications/g8-science-ministers-statement-london-12-june-2013]. Greenberg, D. (2007). Science for sale: The perils, rewards, and delusions of campus capitalism. Chicago, IL: University of Chicago Press. Greenberg, D. S. (2001). Science, money, and politics: Political triumph and ethical erosion. Chicago, IL: University of Chicago Press. Harding, S. (2015). Objectivity and diversity: Another logic of scientific research. Chicago, IL: University of Chicago Press. Holman, B. y Elliott, K. (2018). The promise and perils of industryfunded science. Philosophy Compass, 13(2), e12544. Kitcher, P. (2001). Science, truth, and democracy. Oxford, UK: Oxford University Press. Kitcher, P. (2011). Science in a democratic society. Nueva York, NY: Prometheus Books. Koskinen, I. Y Mäki, U. (2016). Extra-academic transdisciplinarity and scientific pluralism: What might they learn from one another? European Journal for Philosophy of Science, 6(3), 419-444. Kourany, J. (2010). Philosophy of science after feminism. Oxford, UK: Oxford University Press. Leonelli, S. (2013). Why the current insistence on open access to scientific data? big data, knowledge production, and the political economy of contemporary biology. Bulletin of Science, Technology & Society, 33(1-2), 6-11. Levin, N., Leonelli, S., Weckowska, D. et al. (2016). How do scientists define openness? exploring the relationship between open science policies and research practice. Bulletin of Science, Technology & Society, 36(2), 128-141. Lexchin, J., Bero, L., Djulbegovic, B. et al. (2003). Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. British Medical Journal, 326(7400), 1167-1170. Longino, H. E. (2002). The fate of knowledge. Princeton, NJ: Princeton University Press. Lundh, A., Lexchin, J., Mintzes, B. et al. (2017). Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews, 2(2), 33. Markowitz, G. y Rosner, D. (2002). Deceit and denial: The deadly politics of industrial pollution. California: Milbank Books on Health and the Public. Maurer, S. (2007). Open source drug discovery: Finding a niche (or maybe several). UMKC Latin American Law Review, 76, 405-434. McGarity, T. O. y Wagner, W. E. (2008). Bending science: How special interests corrupt Public health research. Cambridge, MA: Harvard University Press. Merton, R. (1974). The sociology of science: Theoretical and empirical investigations. Chicago, IL: University of Chicago Press. Meskus, M., Marelli, L. y D’Agostino, G. (2018). Research misconduct in the age of open science: The case of STAP stem cells. Science as Culture, 27(1), 1-23. Michaels, D. (2008). Doubt is their product: How industry’s assault on science threatens your health. Nueva York: Oxford University Press. Mirowski, P. (2018). The future(s) of open science. Social Studies of Science, 48(2), 171-203. Murray R., P., Neylon, C., Pollock, R. y Wilbanks, J. (2010). Panton principles, principles for open data in science. Panton Principles,[https://pantonprinciples.org/]. National Science Board (2018). Science and engineer indicators 2018. NSB-2018-1. Alexandria, VA: NSF, [https://www.nsf. gov/statistics/ indicators/]. Nielsen, M. (2011a). Reinventing discovery: The new era of networked science. Princeton, NJ: Princeton University Press. Nielsen, M. (2011b). Open science now. TED talk, [https://www.ted.com/talks/Michael_nielsen_open_science_now]. OCDE. (2015). Making open science a reality. OECD science, technology and industry policy papers, 25. París: OECD Publishing, [https:// www.oecdilibrary. org/science-and-technology/making-open-sciencea-reality_5jrs2f963zs1-en]. Oreskes, N. y Conway, E. M. (2010). Merchants of doubt: How a handful of scientists obscured the truth on issues from tobacco smoke to global warming. Nueva York: Bloomsbury Publishing. Phelps, L., Fox, B. A. y Marincola, F. M. (2012). Supporting the advancement of science: Open access publishing and the role of mandates. Journal of Translational Medicine, 10(13), 34-49. Powell, M. y Colin, M. (2009). Participatory paradoxes: Facilitating citizen engagement in science and technology from the top-down? Bulletin of Science, Technology & Society, 29(4), 325-342. Proctor, R. N. (2011). Golden holocaust: Origins of the cigarette catastrophe and the case for abolition. Berkeley, CA: University of California Press. Radder, H. (2010). The commodification of academic research: Science and the modern university. Pittsburgh, PA: University of Pittsburgh Press. Resnik, D. B. (2007). The price of truth: How money affects the norms of science. Oxford, UK: Oxford University Press. Royal Society (2012). Report 02/12 DES2482. Science as an open enterprise, [https://royalsociety.org//media/policy/projects/sape/2012-06- 20-saoe.pdf ]. Sappington, T. W., Ostlie, K. R., DiFonzo et al. (2010). Conducting public-sector research on commercialized transgenic seed. GM Crops & Food, 1(2), 55-58. Schroeder, R. (2007). E-research infrastructures and open science: Towards a new system of knowledge production? Prometheus 25(1), 1-17. Sidler, M. (2014). Open science and the three cultures: Expanding open science to all domains of knowledge creation. En S. Bartling y S. Friesike (eds.), Opening science: The evolving guide on how the internet is changing research (pp. 81-85). Dordrecht, Netherlands: Springer. Sismondo, S. (2007). Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Medicine, 4(9), 286. Sismondo, S. (2008). Pharmaceutical company funding and its consequences: A qualitative systematic review. Contemporary Clinical Trials, 29(2), 109-113. Sismondo, S. (2009). Ghosts in the machine: Publication planning in the medical sciences. Social Studies of Science, 39(2), 171-198. Slaughter, S. y Rhoades, G. (2004). Academic capitalism and the new economy: Markets, state, and higher education. Baltimore, MD: Johns Hopkins University Press. Smith, R. (2003). Medical journals and pharmaceutical companies: Uneasy bedfellows. British Medical Journal, 326(7400), 1202-1205. Turner, E., Matthews, A., Linardatos, E. et al. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine, 358, 252-260. Unesco. (2012). Policy guidelines for the development and Promotion of open access. United Nations Educational, Scientific and Cultural Organization, [http://unesdoc.unesco.org/images/0021/002158/215863e.pdf ]. Unesco. (2015). Unesco science report: Towards 2030, [https://en. unesco.org/unescosciencereport]. Waltz, E. (2009). Under wraps. Nature. Biotechnology, 27(10), 880-882. Wise, N. (2006). Thoughts on the politicization of science through commercialization. Social Research, 73(4), 1253-1272. Wylie, A. (2015). A plurality of pluralisms: Collaborative practice in archaeology. En F. Padovani, A. Richardson y J. Tsou (eds.), Objectivity in science: New perspectives from science and technology studies (pp. 189-210). Dordrecht: Springer.
dc.rights.spa.fl_str_mv	Manuela Fernández Pinto - 2022
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.uri.spa.fl_str_mv	http://creativecommons.org/licenses/by-nc-sa/4.0
rights_invalid_str_mv	Manuela Fernández Pinto - 2022 http://purl.org/coar/access_right/c_abf2 http://creativecommons.org/licenses/by-nc-sa/4.0
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad Externado de Colombia
dc.source.spa.fl_str_mv	https://revistas.uexternado.edu.co/index.php/ecoins/article/view/7964
institution	Universidad Externado de Colombia
bitstream.url.fl_str_mv	https://bdigital.uexternado.edu.co/bitstreams/840299d7-5ab4-408e-bfe0-2a8d2954775d/download
bitstream.checksum.fl_str_mv	2fdac96eb3fccf4f480de0617756aa25
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Universidad Externado de Colombia
repository.mail.fl_str_mv	metabiblioteca@metabiblioteca.org
_version_	1814100509394468864
spelling	Fernández Pinto, Manuelab06c0186-131a-4e30-ae32-a7b6107ba54a2022-07-01 14:04:062022-09-09T21:19:30Z2022-07-01 14:04:062022-09-09T21:19:30Z2022-07-01Los conflictos de intereses, los casos de fraude científico y las limitaciones a la investigación por las leyes de propiedad intelectual han llevado a cuestionar la idoneidad epistémica y de justicia social de la investigación financiada por la industria. El ideal de Ciencia Abierta –que promueve la transparencia, la colaboración y la rendición de cuentas– parece abordar las limitaciones de la investigación impulsada comercialmente. Sin embargo, el movimiento de Ciencia Abierta se centra en la investigación financiada con fondos públicos, alienta los lazos con el sector privado y crea nuevas estrategias para comercializar la ciencia. Así, la Ciencia Abierta termina contribuyendo a la comercialización de la ciencia y no a superar sus limitaciones; y la asimetría entre ciencia privada y pública, presente en la actual apelación a la ciencia abierta, termina comprometiendo los valores que promueve el ideal.Conflicts of interest, cases of scientific fraud, and limitations on research by intellectual property laws have led to questions about the epistemic and social justice adequacy of industry-funded research. The Open Science ideal - which promotes transparency, collaboration, and accountability-seems to address the limitations of commercially driven research. However, the Open Science movement focuses on publicly funded research, encourages ties to the private sector, and creates new strategies for commercializing science. Thus, Open Science ends up contributing to the commercialization of science rather than overcoming its limitations; and the asymmetry between private and public science, present in the current plea to Open Science, ends up compromising the values that this ideal promotes.application/pdf10.18601/01245996.v24n47.082346-24500124-5996https://bdigital.uexternado.edu.co/handle/001/12302https://doi.org/10.18601/01245996.v24n47.08spaUniversidad Externado de Colombiahttps://revistas.uexternado.edu.co/index.php/ecoins/article/download/7964/11990Núm. 47 , Año 2022 : Julio-Diciembre2014717924Revista de Economía InstitucionalAndrade, C. (2015). The primary outcome measure and its importance in clinical trials. Journal of Clinical Psychiatry, 76(10), e1320-e1323. Bartling, S. y Friesike, S. (2014). Towards another scientific revolution. En S. Bartling y S. Friesike (eds.), Opening science: The evolving guide on how the internet is changing research (pp. 3-16). Dordrecht, Netherlands: Springer. Bekelman, J., Li, Y. y Gross, C. (2003). Scope and impact of financial conflicts of interest in biomedical research: A systematic review. Journal of the American Medical Association, 289(4), 454-465. Biddle, J. (2007). Lessons from the Vioxx debacle: What the privatization of science can teach us about social epistemology. Social Epistemology, 21(1), 21-39. Biddle, J. (2014). Can patents prohibit research? On the social epistemology of patenting and licensing in science. Studies in History and Philosophy of Science, 45(1), 14-23. Bok, D. (2003). Universities in the marketplace: The commercialization of higher education. Princeton, NJ: Princeton University Press. Doucet, M. y Sismondo, S. (2008). Evaluating solutions to sponsorship bias. Journal of Medical Ethics, 34(8), 627-630. Douglas, H. (2009). Science, policy, and the value-free ideal. Pittsburgh, PA: University of Pittsburgh Press. Elliott, K. (2008). Scientific judgment and the limits of conflict-ofinterest policies. Accountability in Research Policies and Quality Assurance, 15(1), 1-29. Elliott, K. (2019). The kaleidoscope of citizen science. Narrative Inquiry in Bioethics, 9(1), 47-52. EU Presidency. (2016). Amsterdam call for action on open science, [https://f-origin.hypotheses.org/wp-content/blogs.dir/1244/files/ 2016/06/amsterdam-call-for-action-on-open-science.pdf ]. European Commission for Research and Innovation. (2016). Guidelines on open access to scientific publications and research data in horizon 2020, [http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/oa_pilot/h2020-hi-oa-pilot-guide_en.pdf ]. Eurostat. (2018). The EU in the World, [https://ec.europa.eu/ eurostat/en/web/products-statistical-books/-/KS-EX-18-001]. Fecher, B. y Friesike, S. (2014). Open science: One term, five schools of thought. En S. Bartling y S. Friesike (eds.), Opening science: The evolving guide on how the internet is changing research (pp. 17-47). Dordrecht, Netherlands: Springer. Fernández Pinto, M. (2017). To know or better not to: Agnotology and the social construction of ignorance in commercially driven research. Science & Technology Studies, 30(2), 53-72. Fernández Pinto, M. (2018). Democratizing strategies for industryfunded medical research: A cautionary tale. Philosophy of Science, 85(5), 882-894. G8 Summit. (2013). Science Ministers statement, [https://www.gov.uk/government/publications/g8-science-ministers-statement-london-12-june-2013]. Greenberg, D. (2007). Science for sale: The perils, rewards, and delusions of campus capitalism. Chicago, IL: University of Chicago Press. Greenberg, D. S. (2001). Science, money, and politics: Political triumph and ethical erosion. Chicago, IL: University of Chicago Press. Harding, S. (2015). Objectivity and diversity: Another logic of scientific research. Chicago, IL: University of Chicago Press. Holman, B. y Elliott, K. (2018). The promise and perils of industryfunded science. Philosophy Compass, 13(2), e12544. Kitcher, P. (2001). Science, truth, and democracy. Oxford, UK: Oxford University Press. Kitcher, P. (2011). Science in a democratic society. Nueva York, NY: Prometheus Books. Koskinen, I. Y Mäki, U. (2016). Extra-academic transdisciplinarity and scientific pluralism: What might they learn from one another? European Journal for Philosophy of Science, 6(3), 419-444. Kourany, J. (2010). Philosophy of science after feminism. Oxford, UK: Oxford University Press. Leonelli, S. (2013). Why the current insistence on open access to scientific data? big data, knowledge production, and the political economy of contemporary biology. Bulletin of Science, Technology & Society, 33(1-2), 6-11. Levin, N., Leonelli, S., Weckowska, D. et al. (2016). How do scientists define openness? exploring the relationship between open science policies and research practice. Bulletin of Science, Technology & Society, 36(2), 128-141. Lexchin, J., Bero, L., Djulbegovic, B. et al. (2003). Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. British Medical Journal, 326(7400), 1167-1170. Longino, H. E. (2002). The fate of knowledge. Princeton, NJ: Princeton University Press. Lundh, A., Lexchin, J., Mintzes, B. et al. (2017). Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews, 2(2), 33. Markowitz, G. y Rosner, D. (2002). Deceit and denial: The deadly politics of industrial pollution. California: Milbank Books on Health and the Public. Maurer, S. (2007). Open source drug discovery: Finding a niche (or maybe several). UMKC Latin American Law Review, 76, 405-434. McGarity, T. O. y Wagner, W. E. (2008). Bending science: How special interests corrupt Public health research. Cambridge, MA: Harvard University Press. Merton, R. (1974). The sociology of science: Theoretical and empirical investigations. Chicago, IL: University of Chicago Press. Meskus, M., Marelli, L. y D’Agostino, G. (2018). Research misconduct in the age of open science: The case of STAP stem cells. Science as Culture, 27(1), 1-23. Michaels, D. (2008). Doubt is their product: How industry’s assault on science threatens your health. Nueva York: Oxford University Press. Mirowski, P. (2018). The future(s) of open science. Social Studies of Science, 48(2), 171-203. Murray R., P., Neylon, C., Pollock, R. y Wilbanks, J. (2010). Panton principles, principles for open data in science. Panton Principles,[https://pantonprinciples.org/]. National Science Board (2018). Science and engineer indicators 2018. NSB-2018-1. Alexandria, VA: NSF, [https://www.nsf. gov/statistics/ indicators/]. Nielsen, M. (2011a). Reinventing discovery: The new era of networked science. Princeton, NJ: Princeton University Press. Nielsen, M. (2011b). Open science now. TED talk, [https://www.ted.com/talks/Michael_nielsen_open_science_now]. OCDE. (2015). Making open science a reality. OECD science, technology and industry policy papers, 25. París: OECD Publishing, [https:// www.oecdilibrary. org/science-and-technology/making-open-sciencea-reality_5jrs2f963zs1-en]. Oreskes, N. y Conway, E. M. (2010). Merchants of doubt: How a handful of scientists obscured the truth on issues from tobacco smoke to global warming. Nueva York: Bloomsbury Publishing. Phelps, L., Fox, B. A. y Marincola, F. M. (2012). Supporting the advancement of science: Open access publishing and the role of mandates. Journal of Translational Medicine, 10(13), 34-49. Powell, M. y Colin, M. (2009). Participatory paradoxes: Facilitating citizen engagement in science and technology from the top-down? Bulletin of Science, Technology & Society, 29(4), 325-342. Proctor, R. N. (2011). Golden holocaust: Origins of the cigarette catastrophe and the case for abolition. Berkeley, CA: University of California Press. Radder, H. (2010). The commodification of academic research: Science and the modern university. Pittsburgh, PA: University of Pittsburgh Press. Resnik, D. B. (2007). The price of truth: How money affects the norms of science. Oxford, UK: Oxford University Press. Royal Society (2012). Report 02/12 DES2482. Science as an open enterprise, [https://royalsociety.org//media/policy/projects/sape/2012-06- 20-saoe.pdf ]. Sappington, T. W., Ostlie, K. R., DiFonzo et al. (2010). Conducting public-sector research on commercialized transgenic seed. GM Crops & Food, 1(2), 55-58. Schroeder, R. (2007). E-research infrastructures and open science: Towards a new system of knowledge production? Prometheus 25(1), 1-17. Sidler, M. (2014). Open science and the three cultures: Expanding open science to all domains of knowledge creation. En S. Bartling y S. Friesike (eds.), Opening science: The evolving guide on how the internet is changing research (pp. 81-85). Dordrecht, Netherlands: Springer. Sismondo, S. (2007). Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Medicine, 4(9), 286. Sismondo, S. (2008). Pharmaceutical company funding and its consequences: A qualitative systematic review. Contemporary Clinical Trials, 29(2), 109-113. Sismondo, S. (2009). Ghosts in the machine: Publication planning in the medical sciences. Social Studies of Science, 39(2), 171-198. Slaughter, S. y Rhoades, G. (2004). Academic capitalism and the new economy: Markets, state, and higher education. Baltimore, MD: Johns Hopkins University Press. Smith, R. (2003). Medical journals and pharmaceutical companies: Uneasy bedfellows. British Medical Journal, 326(7400), 1202-1205. Turner, E., Matthews, A., Linardatos, E. et al. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine, 358, 252-260. Unesco. (2012). Policy guidelines for the development and Promotion of open access. United Nations Educational, Scientific and Cultural Organization, [http://unesdoc.unesco.org/images/0021/002158/215863e.pdf ]. Unesco. (2015). Unesco science report: Towards 2030, [https://en. unesco.org/unescosciencereport]. Waltz, E. (2009). Under wraps. Nature. Biotechnology, 27(10), 880-882. Wise, N. (2006). Thoughts on the politicization of science through commercialization. Social Research, 73(4), 1253-1272. Wylie, A. (2015). A plurality of pluralisms: Collaborative practice in archaeology. En F. Padovani, A. Richardson y J. Tsou (eds.), Objectivity in science: New perspectives from science and technology studies (pp. 189-210). Dordrecht: Springer.Manuela Fernández Pinto - 2022info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.http://creativecommons.org/licenses/by-nc-sa/4.0https://revistas.uexternado.edu.co/index.php/ecoins/article/view/7964commercialization of science, open science, open access, industry-funded research, democratization of scienceL23, I15, I23comercialización de la ciencia, ciencia abierta, acceso abierto, investigación financiada por la industria, democratización de la cienciaL23, I15, I23comercialização da ciência, ciência aberta, acesso aberto, pesquisa financiada pela indústria, democratização da ciênciaL23, I15, I23¿Ciencia abierta para intereses privados? la lógica de la ciencia abierta y la comercialización de la investigaciónOpen science for private interests? How the logic of open science contributes to the commercialization of researchArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85Textinfo:eu-repo/semantics/articleJournal articlehttp://purl.org/redcol/resource_type/ARTREFinfo:eu-repo/semantics/publishedVersionPublicationOREORE.xmltext/xml2616https://bdigital.uexternado.edu.co/bitstreams/840299d7-5ab4-408e-bfe0-2a8d2954775d/download2fdac96eb3fccf4f480de0617756aa25MD51001/12302oai:bdigital.uexternado.edu.co:001/123022023-08-14 15:29:16.536http://creativecommons.org/licenses/by-nc-sa/4.0Manuela Fernández Pinto - 2022https://bdigital.uexternado.edu.coUniversidad Externado de Colombiametabiblioteca@metabiblioteca.org

¿Ciencia abierta para intereses privados? la lógica de la ciencia abierta y la comercialización de la investigación

Publicaciones similares